Digital Telepathology Market

The digital telepathology market is projected to reach a valuation of USD 934.8 million in 2025 and is expected to reach USD 2,316.6 million by 2035. Demand for digital telepathology is expected to rise at a CAGR of 9.5% over the forecast period. Drug discovery and development is expected to hold a 37.8% share in 2025, which is attributed to its critical role in accelerating biomarker research and enhancing decision-making in clinical trials. Pharmaceutical and biotechnology companies will dominate the end user segment with a 43.7% market share, owing to the rising adoption of digital pathology tools to streamline R&D workflows in drug development pipelines.